T2Bmeets Rescheduled: Boston and NY/NJ
|
Hi! After the snow forced us to postpone our Boston and NY/NJ T2Bmeets earlier this quarter, we’re glad to have them back on the calendar. Following our networking mixer at JPM to start the year, we’re now looking ahead to three in-person T2Bmeets across the country — in Boston (March 31st), New Jersey (April 1st), and San Diego (April 23rd). These meetups combine panel discussion and informal networking, depending on the city. If you’re local (or traveling), we hope you’ll join us for a low-key opportunity to reconnect early in the year. If you weren’t able to join us at JPM in January, we hope one of these meetups gives you a chance to connect with fellow biopharma communicators in person this spring. Lynnea |
T2B Monthly
Hi! While our field has its own regulatory, scientific, and stakeholder complexities, many of the judgment calls we face around trust, executive counsel, reputation, and change aren’t unique to biotech. Communicators in other highly scrutinized sectors often navigate similar pressures, often with lessons that translate in useful ways. Tomorrow’s Comm Convo brings together communications leaders who have worked both inside and outside of biopharma. They’ll share how working in other industries...
Hi, and Happy Friday! At our Q1 IR Roundtable event, How ESG Drives Trust Among Investors and Patients Alike, our guest speakers dug into ESG with a biopharma lens, exploring how we can approach ESG in a way that strengthens credibility. ESG is most effective when it helps stakeholders understand how a company manages risk and makes decisions, rather than being positioned as a separate corporate responsibility exercise. If you weren’t able to join us live, T2B Pro and Student members can...
Hi! At our very first Patient Advocacy & Engagement Roundtable discussion, Patient Stories Without a Fixed Address, the conversation with leaders from Astellas, Bayer, and Atrium Therapeutics focused on what patient centricity looks like when it is treated as a strategic business priority. A consistent theme emerged: Organizations that build strong patient relationships tend to do so by embedding patient perspectives early, operationalizing what they hear, and protecting the integrity of the...